Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rossi

Showing results (141-150 of 194) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Kidney International Reports|December 12, 2022
Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus NephritisGiovanni Maria Rossi, Umberto Maggiore, Francesco Peyronel, et al.
Hematological Oncology|October 3, 2012
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic cloneRoberto Marasca, Rossana Maffei, Silvia Martinelli, et al.
Internal and Emergency Medicine|March 10, 2024
Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre studyCarlo Maria Rossi, Marco Vincenzo Lenti, Stefania Merli, et al.
Haematologica|August 1, 2020
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemiaGiovanni Del Poeta, Annalisa Biagi, Luca Laurenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2020
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseasesValli De Re, Maria Lina Tornesello, Mariangela De Zorzi, et al.
Scientific Reports|July 15, 2025
Disrupted mucosal vascular barrier in eosinophilic esophagitisMarco Vincenzo Lenti, Carlo Maria Rossi, Renato Cannizzaro, et al.
Blood|September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanismAntonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Haematologica|October 30, 2020
<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulationFederico Pozzo, Tamara Bittolo, Erika Tissino, et al.
Hematological Oncology|November 16, 2021
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemiaErika Tissino, Eliana Pivetta, Alessandra Capuano, et al.
Pageof 20

Showing results (141-150 of 194) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Kidney International Reports|December 12, 2022
Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus NephritisGiovanni Maria Rossi, Umberto Maggiore, Francesco Peyronel, et al.
Hematological Oncology|October 3, 2012
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic cloneRoberto Marasca, Rossana Maffei, Silvia Martinelli, et al.
Internal and Emergency Medicine|March 10, 2024
Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre studyCarlo Maria Rossi, Marco Vincenzo Lenti, Stefania Merli, et al.
Haematologica|August 1, 2020
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemiaGiovanni Del Poeta, Annalisa Biagi, Luca Laurenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2020
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseasesValli De Re, Maria Lina Tornesello, Mariangela De Zorzi, et al.
Scientific Reports|July 15, 2025
Disrupted mucosal vascular barrier in eosinophilic esophagitisMarco Vincenzo Lenti, Carlo Maria Rossi, Renato Cannizzaro, et al.
Blood|September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanismAntonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Haematologica|October 30, 2020
<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulationFederico Pozzo, Tamara Bittolo, Erika Tissino, et al.
Hematological Oncology|November 16, 2021
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemiaErika Tissino, Eliana Pivetta, Alessandra Capuano, et al.
Pageof 20